Bayesian Capital Management’s Dynatrace DT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,046
Closed -$521K 630
2025
Q1
$521K Buy
+11,046
New +$604K 0.09% 284
2024
Q4
Sell
-28,200
Closed -$1.51M 759
2024
Q3
$1.51M Sell
28,200
-45,900
-62% -$2.19M 0.18% 170
2024
Q2
$3.32M Buy
+74,100
New +$3.41M 0.38% 57
2023
Q3
Sell
-54,500
Closed -$2.81M 769
2023
Q2
$2.81M Sell
54,500
-2,700
-5% -$127K 0.3% 76
2023
Q1
$2.42M Buy
+57,200
New +$2.32M 0.3% 92
2020
Q3
Sell
-37,882
Closed -$1.54M 556
2020
Q2
$1.54M Sell
37,882
-8,600
-19% -$283K 0.34% 68
2020
Q1
$1.11M Buy
+46,482
New +$1.34M 0.24% 105

Other funds holding DT

Bayesian Capital Management's DT Position: Q2 2025 in Review

Bayesian Capital Management sold out of Dynatrace (DT) in Q2 2025, closing a stake of 11,046 shares — an estimated $521K sold.

Bayesian Capital Management first reported a position in DT in Q1 2020 and held it in 7 quarters. The position peaked at $3.32M in Q2 2024. 626 funds tracked by Wall St. Rank hold DT as of Q2 2025.

  • Bayesian Capital Management reported no remaining Dynatrace position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 11,046 Dynatrace shares in Q2 2025, an estimated $521K.
  • Bayesian Capital Management first reported a position in Dynatrace in Q1 2020 and held it in 7 quarters.
  • Bayesian Capital Management's Dynatrace position peaked at $3.32M in Q2 2024.
  • 626 funds tracked by Wall St. Rank held Dynatrace as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.